Arch closes $3B-plus fund as biotech investment environment shows more signs of a revival January 9, 20240CommentsOn the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with the other investor, closing a VC fund…Read More
